Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach

REFERENCES

• Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the manage-ment of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: rec-ommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.
   PubMed Web of Science ®Google Scholar
• Mease PJ. Improving the routine management of rheumatoid arthritis: the value of tight control. J Rheumatol. 2010;37:1570–8.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthr Rheum. 2010;62: 2569–81.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69: 1580–8.
   Google Scholar
• Tamai M, Kawakami K, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrist and finger joints and serologic autoantibodies. Arthr Rheum. 2009;61:772–8.
   PubMed Web of Science ®Google Scholar
• Hodgson RJ, O'Connor P, Moots R. MRI of rheumatoid arthri-tis-image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology. 2008;47: 13–21.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Pedersen SJ, DOhn UM. Imaging in rheumatoid arthritis-status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conven-tional radiography. Best Pract Res Clin Rheumatol. 2008;22: 1019–44.
   Google Scholar
• Hetland M, Ejbjerg B, Horslev-Petersen K, Jacobsen S, Vest-ergaard A, Junk AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheu-matoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68: 384–90.
   Google Scholar
• Hetland M, Stengaard-Pedersen K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis-MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010;69:1789–95.
   PubMed Web of Science ®Google Scholar
• Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri S, et al. Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration. Mod Rheumatol. 2011.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Fujikawa K, et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheu-matoid arthritis. J Rheumatol. 2007;34:2154–7.
   PubMed Web of Science ®Google Scholar
• Tamai M, Kawakami A, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, et al. Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by MRI of wrist and finger joints and physical examination. Arthritis Care Res. 2011;63:436–9.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21:663–75.
   PubMed Web of Science ®Google Scholar
• Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nakajima A, et al. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis. Mod Rheumatol. 2011;21:444–8.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Carotti M, Ciapetti A, Gasparini S, Filippucci E, Grassi W. Relationship between time-integrated disease activity esti-mated by DA528-CRP and radiographic progression of anatom-ical damage in patients with early rheumatoid arthritis. BMC Musculoskelet Disord. 2011;12:120.
   PubMedGoogle Scholar
• Haavardsholm EA, Ostergaard M, Hammer HB, Boyesen P, Boonen A, van der Heijde D, et al. Monitoring anti-TNFa treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage. Ann Rheum Dis. 2009;68:1572–9.
   Google Scholar
• Emery P, Durez P, Dougados M, Legerton CW, Becker J-C, Vratsanos G, et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis. 2010;69:510–6.
   Google Scholar
• Schett G. Bone marrow edema. Ann N Y Acad Sci. 2009;1154: 35–40.
   PubMedGoogle Scholar